Cargando…

Profile of certolizumab and its potential in the treatment of psoriatic arthritis

Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy associated with psoriasis (PsO). PsA could be considered an enthesal disease because of the link between mechanical stress (entheses) and immunologically active tissue (synovium). Evidence of efficacy of anti-tumor necrosis factor alpha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chimenti, Maria Sole, Saraceno, Rosita, Chiricozzi, Andrea, Giunta, Alessandro, Chimenti, Sergio, Perricone, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633576/ https://www.ncbi.nlm.nih.gov/pubmed/23620660 http://dx.doi.org/10.2147/DDDT.S31658

Ejemplares similares

S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2020)

Downregulation of Immunoglobulin-Like Transcript-4 (ILT4) in Patients with Psoriatic Arthritis
por: Bergamini, Alberto, et al.
Publicado: (2014)

Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
por: Saraceno, Rosita, et al.
Publicado: (2013)

Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Capillaroscopy in Psoriatic and Rheumatoid Arthritis: A Useful Tool for Differential Diagnosis
por: Graceffa, Dario, et al.
Publicado: (2013)

Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress
por: Chimenti, Maria Sole, et al.
Publicado: (2018)

Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence
por: Costa, Luisa, et al.
Publicado: (2017)

Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study
por: Teoli, M., et al.
Publicado: (2012)

Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study
por: Chimenti, Maria Sole, et al.
Publicado: (2019)

A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation †
por: Chimenti, Maria Sole, et al.
Publicado: (2020)

Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis
por: Hum, Ryan M, et al.
Publicado: (2022)

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future
por: Navarini, Luca, et al.
Publicado: (2020)

Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Psoriatic Arthritis in Males and Females: Differences and Similarities
por: Lubrano, Ennio, et al.
Publicado: (2023)

Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis
por: Scriffignano, Silvia, et al.
Publicado: (2023)

Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab
por: Conigliaro, Paola, et al.
Publicado: (2016)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
por: Acosta-Felquer, María Laura, et al.
Publicado: (2016)

Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
por: Dattola, Annunziata, et al.
Publicado: (2017)

IL-6 as a Druggable Target in Psoriasis: Focus on Pustular Variants
por: Saggini, Andrea, et al.
Publicado: (2014)

Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice
por: Babino, Graziella, et al.
Publicado: (2016)

Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab
por: Chimenti, Maria Sole, et al.
Publicado: (2013)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi, Andrea, et al.
Publicado: (2019)

Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection
por: Ohmura, Shin-ichiro, et al.
Publicado: (2021)

EP19 Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis: a case report
por: Hum, Ryan Malcolm, et al.
Publicado: (2020)

Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor
por: Conigliaro, Paola, et al.
Publicado: (2016)

Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Impact of TRAF3IP2, IL10 and HCP5 Genetic Polymorphisms in the Response to TNF-i Treatment in Patients with Psoriatic Arthritis
por: De Benedittis, Giada, et al.
Publicado: (2022)

PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre study
por: Chimenti, Maria Sole, et al.
Publicado: (2019)

The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
por: Blauvelt, Andrew, et al.
Publicado: (2018)

Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
por: D'Angelo, Salvatore, et al.
Publicado: (2019)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone, Monica, et al.
Publicado: (2014)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
por: Giunta, Alessandro, et al.
Publicado: (2017)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Khan, Abdul, et al.
Publicado: (2011)

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature
por: Rutkowski, David, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ojt6p9acecnosn4ajgu63ccrkv